Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival

Letter/Communication

Edoardo Francini, Anna I. Fiaschi, Roberto Petrioli, Vincenzo Bianco, Letizia Laera, Filippo Francini and Giandomenico Roviello

Anti-cancer drugs, Vol.26(8), pp.910-911

09/2015

DOI: 10.1097/CAD.0000000000000258

PMID: 26207428

View Online

Oncology

Life Sciences & Biomedicine

Pharmacology & Pharmacy

Science & Technology

Title: Subtitle: Abiraterone in heavily pretreated patients with metastatic castrate-resistant prostate cancer: final analysis of overall survival
Creators: Edoardo Francini - University of Siena
Anna I. Fiaschi - Brain Physiology Lab
Roberto Petrioli - University of Siena
Vincenzo Bianco - Policlinico Umberto I
Letizia Laera - University of Siena
Filippo Francini - University of Siena
Giandomenico Roviello - University of Siena
Resource Type: Letter/Communication
Publication Details: Anti-cancer drugs, Vol.26(8), pp.910-911
DOI: 10.1097/CAD.0000000000000258
PMID: 26207428
ISSN: 0959-4973
eISSN: 1473-5741
Publisher: Lippincott Williams & Wilkins
Number of pages: 2
Language: English
Date published: 09/2015
Academic Unit: Internal Medicine
Record Identifier: 9985221242702771

1 Record Views